Cognitive impairment and its relation to imaging measures in multiple sclerosis: A study using a computerized battery

Journal of Neuroimaging

Volumn 23, Issue 3, 2013, Pages 445-452

  Pellicano, Clelia ^a   Kane, Robert L ^b   Gallo, Antonio ^a   Xiaobai, Li ^a   Stern, Susan K ^a   Ikonomidou, Vasiliki N ^a   Evangelou, Iordanis E ^a   Ohayon, Joan M ^a   Ehrmantraut, Mary ^a   Cantor, Fredric K ^a   Bagnato, Francesca ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

3TMRI; ANAM; Cognitive impairment; Computerized batteries; Multiple sclerosis

Indexed keywords

ADULT; ARTICLE; AUTOMATED NEUROPSYCHOLOGICAL ASSESSMENT METRICS; AUTOMATION; BRAIN SIZE; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CORTICAL THICKNESS (BRAIN); DISEASE ASSOCIATION; FEMALE; GRAY MATTER; HUMAN; INDEX OF COGNITIVE EFFICIENCY; MALE; MEMORY; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; TASK PERFORMANCE; WHITE MATTER; ADOLESCENT; BRAIN; CASE CONTROL STUDY; COGNITION DISORDERS; COMPARATIVE STUDY; COMPLICATION; COMPUTER ASSISTED DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; PROCEDURES; REFERENCE VALUE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; STATISTICS; YOUNG ADULT;

ADOLESCENT; ADULT; BRAIN; CASE-CONTROL STUDIES; COGNITION DISORDERS; DATA INTERPRETATION, STATISTICAL; DIAGNOSIS, COMPUTER-ASSISTED; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; GRAY MATTER; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TESTS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STATISTICS AS TOPIC; WHITE MATTER; YOUNG ADULT;

EID: 84879840446     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/j.1552-6569.2011.00687.x     Document Type: Article

References (45)

1. Bobholz JA, Rao SM. Cognitive dysfunction in multiple sclerosis: a review of recent developments. Curr Opin Neurol 2003;16:283-288.
2. Stankiewicz JM, Glanz BI, Healy BC, et al. Brain MRI Lesion Load at 1.5T and 3T versus Clinical Status in Multiple Sclerosis. J Neuroimag 2011;21(2):e50-e56, doi:10.1111/j.1552-6569.2009.00449.x.
3. Kane RL, Roebuck-Spencer T, Short P, et al. Identifying and monitoring cognitive deficits in clinical populations using Automated Neuropsychological Assessment Metrics (ANAM) tests. Arch Clin Neuropsychol 2007;22(S1):s115-s126.
4. Wilken JA, Kane R, Sullivan CL, et al. The utility of computerized neuropsychological assessment of cognitive dysfunction in patients with relapsing-remitting multiple sclerosis. Mult Scler 2003;9:119-127.
5. Short P, Cernich A, Wilken JA, et al. Initial construct validation of frequently employed ANAM measures through structural equation modeling. Arch Clin Neuropsychol 2007;22(S1):s63-s78.
6. Edgar C, Jongen PJ, Sanders E, et al. Cognitive performance in relapsing remitting multiple sclerosis: a longitudinal study in daily practice using a brief computerized cognitive battery. BMC Neurol 2011;7 11:68. Available at: http://www.biomedcentral.com/1471-2377/11/68 (accessed September 15, 2011).
7. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121-127.
8. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-1452.
9. Cutter GR, Baier ML, Rudick RA, et al. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 1999;122:871-882.
10. Goodkin DE, Hertsgaard D, Seminary J. Upper extremity function in multiple sclerosis: improving assessment sensitivity with box-and-block and nine-hole peg tests. Arch Phys Med Rehabil 1988;69:850-854.
11. Richert ND, Ostuni JL, Bash CN, et al. Interferon beta-1b and intravenous methylprednisolone promote lesion recovery in multiple sclerosis. Mult Scler 2001;7:49-58.
12. Wilkinson, GS. The Wide Range Achievement Test: Manual (3rd ed). Wilmington, DE: Wide Range, 1993.
13. Reeves DL, Winter KP, Bleiberg J, et al. ANAM genogram: historical perspectives, description, and current endeavors. Arch Clin Neuropsychol 2007;22s:15-37.
14. Thorne DR. Throughput: a simple performance index with desirable characteristics. Behav Res Methods 2006;38:569-573.
15. Pellicano C, Gallo A, Li X, et al. Relationship of cortical atrophy to fatigue in patients with multiple sclerosis. Arch Neurol 2010;67:447-453.
16. Bomboi G, Ikonomiodu V, Pellegrini S, et al. Quality and quantity of diffuse and focal white matter disease and cognitive disability of patients with Multiple Sclerosis. J Neuroimag 2011;21:e57-e63.
17. Collins DL, Neelin P, Peters TM, et al. Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J Comput Assist Tomogr 1994;18:192-205.
18. Jenkinson M, Smith SM. A global optimisation method for robust affine registration of brain images. Med Image Anal 2011;5:143-156.
19. Smith SM, Zhang Y, Jenkinson M, et al. Accurate, robust and automated longitudinal and cross-sectional brain change analysis. NeuroImage 2002;17:479-489.
20. Stevenson VL, Smith SM, Matthews PM, et al. Monitoring disease activity and progression in primary progressive multiple sclerosis using MRI: sub-voxel registration to identify lesion changes and to detect cerebral atrophy. J Neurol 2006;249:171-177.
21. Amato MP, Portaccio E, Goretti B, et al. Cognitive impairment in early stages of multiple sclerosis. Neurol Sci 2010;31(Suppl 2):S211-S214.
22. Chiaravalloti ND, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol 2008;7:1139-1151.
23. Dineen RA, Vilisaar J, Hlinka J, et al. Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis. Brain 2009;132:239-249.
24. Benedict RH, Fischer JS, Archibald CJ, et al. Minimal neuropsychological assessment of MS patients: a consensus approach. Clin Neuropsychol 2002;16:381-397.
25. Roosendaal SD, Geurts JJ, Vrenken H, et al. Regional DTI differences in multiple sclerosis patients. Neuroimage 2009;44:1397-1403.
26. Filippi M, Tortorella C, Rovaris M, et al. Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosis. J Neurol Neurosurg Psychiatry 2000;68:157-161.
27. Lund H, Jønsson A, Andresen J, et al. Cognitive deficits in multiple sclerosis: correlations with T2 changes in normal appearing brain tissue. Acta Neurol Scand 2011;doi:10.1111/j.1600-0404.2011.01574.x.
28. Morgen K, Sammer G, Courtney SM, et al. Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing-remitting MS. Neuroimage 2006;30:891-898.
29. Ranjeva JP, Audoin B, Au Duong MV, et al. Structural and functional surrogates of cognitive impairment at the very early stage of multiple sclerosis. J Neurol Sci 2006;245:161-167.
30. Brass SD, Benedict RH, Weinstock-Guttman B, et al. Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis. Mult Scler 2006;12:437-444.
31. Tekok-Kilic A, Benedict RH, Weinstock-Guttman B, et al. Independent contributions of cortical gray matter atrophy and ventricle enlargement for predicting neuropsychological impairment in multiple sclerosis. Neuroimage 2007;15:1294-1300.
32. Houtchens MK, Benedict RH, Killiany R, et al. Thalamic atrophy and cognition in multiple sclerosis. Neurology 2007;69:1213-1223.
33. Benedict RH, Ramasamy D, Munschauer F, et al. Memory impairment in Multiple Sclerosis: correlation with deep gray matter and mesial temporal atrophy. J Neurol Neurosurg Psychiatry 2009;80:201-206.
34. Calabrese M, Rinaldi F, Mattisi I, et al. Widespread cortical thinning characterizes patients with MS with mild cognitive impairment. Neurology 2010;74:321-328.
35. Sanfilipo MP, Benedict RH, Weinstock-Guttman B, et al. Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis. Neurology 2006;66:685-692.
36. Weinstock-Guttman B, Benedict RH, Tamaño-Blanco M, et al. The rs2030324 SNP of brain-derived neurotrophic factor (BDNF) is associated with visual cognitive processing in multiple sclerosis. Pathophysiology 2010;18:43-52.
37. Batista S, Zivadinov R, Hoogs M, et al. Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis. J Neurol 2011;259:139-146.
38. Di Filippo M, Picconi B, Tantucci M, et al. Short-term and long-term plasticity at corticostriatal synapses: implications for learning and memory. Behav Brain Res, 2009;199:108-118.
39. Pennartz CM, Berke JD, Graybiel AM, et al. Corticostriatal interactions during learning, memory processing, and decision making. J Neurosci 2009;29:12831-12838.
40. du Boisgueheneuc F, Levy R, Volle E, et al. Functions of the left superior frontal gyrus in humans: a lesion study. Brain 2006;129:3315-3328.
41. Tovar-Moll F, Evangelou IE, Chiu AW, et al. Thalamic involvement and its impact on clinical disability in patients with multiple sclerosis: a diffusion tensor imaging study at 3T. Am J Neuroradiol 2009;30:1380-1386.
42. Hillary FG, Genova HM, Medaglia JD, et al. The nature of processing speed deficits in traumatic brain injury: is less brain more Brain Imaging Behav 2010;4:141-154.
43. Raz E, Jensen JH, Ge Y, et al. Brain iron quantification in mild traumatic brain injury: a magnetic field correlation study. AJNR Am J Neuroradiol 2011;2:1851-1856.
44. Turken A, Whitfield-Gabrieli S, Bammer R, et al. Cognitive processing speed and the structure of white matter pathways: convergent evidence from normal variation and lesion studies. Neuroimage 2008;42:1032-1044
45. Stebbins GT, Gabrieli JD, Shannon KM, et al. Impaired frontostriatal cognitive functioning following posteroventral pallidotomy in advanced Parkinson's disease. Brain Cogn 2000;42:348-363.